Theralase Technologies Inc. (TSXV:TLT)

Theralase Technologies Revenue

Theralase Technologies had revenue of 132.63K CAD in the quarter ending March 31, 2026, with 45.45% growth. This brings the company's revenue in the last twelve months to 857.91K, down -9.60% year-over-year. In the year 2025, Theralase Technologies had annual revenue of 816.47K, down -20.99%.

• Revenue (ttm): 857.91K
• Revenue Growth: -9.60%
• P/S Ratio: 80.99
• Revenue / Employee: 42.90K
• Employees: 20
• Market Cap: 69.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	816.47K	-216.96K	-20.99%
Dec 31, 2024	1.03M	-36.88K	-3.45%
Dec 31, 2023	1.07M	-68.26K	-6.00%
Dec 31, 2022	1.14M	357.93K	45.85%
Dec 31, 2021	780.64K	-148.48K	-15.98%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error